Copperwynd Financial, LLC Novo Nordisk A S Transaction History
Copperwynd Financial, LLC
- $361 Million
- Q1 2025
A detailed history of Copperwynd Financial, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Copperwynd Financial, LLC holds 10,248 shares of NVO stock, worth $710,391. This represents 0.2% of its overall portfolio holdings.
Number of Shares
10,248
Previous 8,068
27.02%
Holding current value
$710,391
Previous $694,000
2.45%
% of portfolio
0.2%
Previous 0.19%
Shares
6 transactions
Others Institutions Holding NVO
# of Institutions
1,767Shares Held
330MCall Options Held
11.3MPut Options Held
15.5M-
Jennison Associates LLC18.8MShares$1.3 Billion0.93% of portfolio
-
Bank Of America Corp Charlotte, NC14.8MShares$1.03 Billion0.08% of portfolio
-
Loomis Sayles & CO L P12.4MShares$859 Million1.24% of portfolio
-
Morgan Stanley New York, NY12.3MShares$854 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa11.9MShares$823 Million0.36% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $156B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...